Drug Abuse Testing Market Report by Product (Analyzers, Rapid Testing Devices, Consumables, Laboratory Services), Sample (Urine, Oral Fluid (Saliva), Hair, Breath, and Others), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Workplaces, and Others), and Region 2024-2032
The global drug abuse testing market size reached US$ 7.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.
Drug abuse is the deliberate consumption of illegal substances or overindulgence of prescribed psychoactive or performance-enhancing chemicals and over-the-counter (OTC) medications. It can affect the mind and body and lead to various disorders like addiction. As a result, it is diagnosed among individuals using different testing methods to provide effective treatment for related disorders. Drug abuse testing also assists in managing acute mental status and seizure cases in the emergency room and identifying children and newborns at risk of exposure to illicit drugs. Nowadays, it finds application in workplaces before hiring an applicant.
Drug Abuse Testing Market Trends:
Presently, drugs like opiates, cannabinoids, cocaine, lysergic acid diethylamide (LSD), barbiturates, amphetamines, alcohol, diazepam, and ketamine are abused for their mind-altering characteristics, non-therapeutic and medicinal uses, and other purposes, including weight loss and enhancing athletic performance. This can lead to drug dependence and substance use disorder, which represents one of the key factors driving the demand for drug abuse testing across the globe. Apart from this, drug abuse can create significant safety and health hazards and decrease the productivity and morale of an individual. This, in turn, is positively influencing the use of drug abuse testing to screen employees and job applicants, provide a safe workplace, and comply with strict government laws and regulations. Moreover, substantial growth in pain management and opioid dependency clinics is catalyzing the demand for urine drug testing worldwide. Furthermore, leading companies are offering automated testing and analysis for drugs of abuse. These companies are also offering at-home use kits for instant drug abuse tests. This, along with the thriving e-commerce industry, is impelling the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global drug abuse testing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, sample and end user.
Breakup by Product:
Analyzers
Immunoassays Analyzers
Chromatographic Devices
Breath Analyzers
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables
Laboratory Services
Breakup by Sample:
Urine
Oral Fluid (Saliva)
Hair
Breath
Others
Breakup by End User:
Hospitals
Diagnostic Laboratories
Forensic Laboratories
Workplaces
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, Omega Laboratories Inc., Quest Diagnostics Incorporated, Siemens AG, Thermo Fisher Scientific Inc. and United States Drug Testing Laboratories Inc.
Key Questions Answered in This Report:
How has the global drug abuse testing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global drug abuse testing market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the sample?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global drug abuse testing market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Drug Abuse Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Analyzers
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Immunoassays Analyzers
6.1.2.2 Chromatographic Devices
6.1.2.3 Breath Analyzers
6.1.3 Market Forecast
6.2 Rapid Testing Devices
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Urine Testing Devices
6.2.2.2 Oral Fluid Testing Devices
6.2.3 Market Forecast
6.3 Consumables
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Laboratory Services
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Sample
7.1 Urine
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral Fluid (Saliva)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Hair
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Breath
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Forensic Laboratories
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Workplaces
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bio-Rad Laboratories Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Danaher Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Drägerwerk AG & Co. KGaA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 F. Hoffmann-La Roche AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 Laboratory Corporation of America Holdings
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Omega Laboratories Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Quest Diagnostics Incorporated
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Siemens AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Thermo Fisher Scientific Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 United States Drug Testing Laboratories Inc.